Senex Biotechnology's Unattributed - IV Round

Senex Biotechnology raised a round of funding on April 18, 2014. Investors include SC Launch.

Senex Biotechnology is a drug discovery company dedicated to becoming the world's leading company that targets a signaling pathway activated by cellular damage and involved in cell senescence (aging).…

Articles about Senex Biotechnology's Unattributed - IV Round: